Role of homoeopathic medicines in management of stress in essential hypertension patients in the age group of 35-80 years.

nil0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patients of both sexes & age group between 35-80 yrs.
•2. Patients presenting with pre-diagnosed mild to moderate essential hypertension without any major systemic complications whose exciting or maintaining cause of essential hypertension is identified to be stress.
•3. Patients on allopathic treatment for essential hypertension fulfilling above two inclusion criterias will be enrolled.
•4. Patients on no allopathic or no homoeopathic treatment (from other doctors for essential hypertension treatment) fulfilling the first
•two inclusion criterias will be enrolled.
•5. The ability to give informed consent & comply with study procedures.

•1. Pregnant or lactating women with essential hypertension.
•2. Patients with severe essential hypertension.
•3. Patients with secondary hypertension.
•4. Patients who require emergency medical interventions or Severe co-morbidities.
•5. Patients on homoeopathic treatment for essential hypertension from another doctor will be excluded.
•6. Simultaneous participation in other clinical studies or completion of participation in a study less than 6 months prior (patients are to
•be explicitly asked about this).

发起方

nil